WASHINGTON, May 30 (UPI) -- The drug goserelin, sold by AstraZeneca under the brand name Zoladex, may help protect the ovaries of women with breast cancer.
"It's not a panacea, but based on these data, it may be the right choice for some patients," study author Dr. Ann H. Partridge, a breast cancer specialist at the Dana-Farber Cancer Institute in Boston, told The New York Times.